Cargando…
Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
BACKGROUND: Asymmetric Dimethylarginine (ADMA) is an inhibitor of endogenous nitric oxide synthase, which is the key synthase for nitric oxide (NO) production. Whether statins could protect endothelium by reducing ADMA concentration is unclear, and whether this effect is associated with the dose of...
Autores principales: | Zheng, Dongdan, Liang, Qing, Zeng, FanFang, Mai, Zhuocheng, Cai, Anping, Qiu, Ruofeng, Xu, Rulin, Li, Dongjuan, Mai, Weiyi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428246/ https://www.ncbi.nlm.nih.gov/pubmed/25934565 http://dx.doi.org/10.1186/s12944-015-0041-2 |
Ejemplares similares
-
Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia
por: Zheng, Dongdan, et al.
Publicado: (2017) -
Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement
por: Zheng, Dongdan, et al.
Publicado: (2014) -
Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)): A Novel and Promising Biomarker for Cardiovascular Risks Assessment
por: Cai, Anping, et al.
Publicado: (2013) -
SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
por: Qiu, Ruofeng, et al.
Publicado: (2012) -
Atorvastatin Treatment of Rats with Ischemia-Reperfusion Injury Improves Adipose-Derived Mesenchymal Stem Cell Migration and Survival via the SDF-1α/CXCR-4 Axis
por: Cai, Anping, et al.
Publicado: (2013)